BioSpace News Archive

As the acquisition of Dublin-based Shire by Japan-based Takeda Pharmaceutical edges forward, yet another major Takeda shareholder has spoken out in opposition to the deal.

AstraZeneca and its MedImmune division released data on overall survival (OS) in its Phase III PACIFIC clinical trial of Imfinzi (durvalumab).

A new cardiovascular imaging tool could prevent the possibility of people experiencing a second or third heart attack.

Making the jump from biotech to politics may not seem like a typical career progression. So, what is driving these executives into politics?

MMJ PhytoTech Ltd (ASX:MMJ) (OTCMKTS:MMJJF) provides the Company’s Annual Report to shareholders.

Swiss pharmaceutical giant Novartis plans to slash approximately 2,200 jobs in Switzerland over the next four years.

Politicians might deny climate change, but disease-carrying insects and their pathogens aren’t—they’re exploiting it.

Ra Pharmaceuticals, Inc. today announced that Doug Treco, PhD, President and Chief Executive Officer of Ra Pharma, will present at the 2018 Cantor Global Healthcare Conference on Tuesday, October 2, 2018 at 9:10 a.m. E.T. The conference is being held at the InterContinental New York Barclay Hotel.

AcelRx Pharmaceuticals Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the use in medically supervised settings, today announced that management will be presenting at the Cantor Fitzgerald Global Healthcare Conference and the Ladenburg Thalmann 2018 Healthcare Conference.

Presentation to be webcast on www.exelixis.com